The Expanding Role of the Pharmacist in HIV Prevention
What Do You Know About PrEP?
Meeting Slides
Clinical Practice Guidelines
Laboratory Testing for the Diagnosis of HIV Infection: Updated Recommendations.
Centers for Disease Control and Prevention, 2014.
STD and HIV Screening Recommendations.
Centers for Disease Control and Prevention, 2017.
US Public Health Service: Preexposure Prophylaxis for the Prevention of HIV Infection in the United States—2014. A Clinical Practice Guideline.
Centers for Disease Control and Prevention, 2014.
ASHP Guidelines on Pharmacist Involvement in HIV Care.
Schafer JJ, et al. Am J Health Syst Pharm. 2016;73(7):468-494.
Clinical Resources
HIV Risk Reduction Estimator
Centers for Disease Control and Prevention, 2017.
PrEP Kit.
AIDS United, 2015.
HIV in the United States by Geographic Distribution.
Centers for Disease Control and Prevention, 2017.
Provider Information Sheet—PrEP During Conception, Pregnancy, and Breastfeeding.
Centers for Disease Control and Prevention.
State HIV Laws.
Centers for Disease Control and Prevention, 2017.
Taking a Sexual History.
NYC Health, 2015.
Transgender Health Learning Center.
University of California, San Francisco, 2017.
HIV Drug Interactions.
University of Liverpool (Web site), 2017.
Patient Resources
HIV Risk Reduction Estimator
Centers for Disease Control and Prevention, 2017.
Centers for Disease Control and Prevention (CDC): HIV Basics
The CDC is a division within the US Department of Health and Human Services (DHHS), the principal agency for protecting the health of all Americans. This comprehensive site provides extensive links to topics across the HIV-care continuum, including PrEP.
Pill-Reminder Smartphone Apps (Free)
Mango Health – Medicine Manager, Pill Reminder for iPhone
Medisafe Pill Reminder, Rx, & Medicine Tracker for iPhone
Medisafe Meds & Pill Reminder for Android
Positively Aware
Positively Aware, created by TPAN (Test Positive Aware Network), is a source of HIV-treatment news for consumers, as well as an educational tool for HIV caregivers. The site features PrEP resources, including videos for MSM and transgender people.
PrEP for U.S. Women: A Collection of Resources
HIVE (Web site).
HIVE provides preconception and prenatal resources for women and couples affected by HIV.
PrEP Locator
PrEP Locator is an online directory of public and private-practice providers of HIV preexposure prophylaxis (PrEP) in the United States. The site includes a map-based widget for ease of locating PrEP services.
Suggested Readings
HIV providers’ likelihood to prescribe pre-exposure prophylaxis (PrEP) for HIV prevention differs by patient type: a short report.
Adams LM, Balderson BH. AIDS Care. 2016;28(9):1154-1158.
Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.
Baeten JM, et al. N Engl J Med. 2012;367(5):399-410.
Pharmacists as providers of HIV preexposure prophylaxis.
Bruno C, Saberi P. Int J Clin Pharm. 2012;34(6):803-806.
Effectiveness of prevention strategies to reduce the risk of acquiring or transmitting HIV.
Centers for Disease Control and Prevention, 2017.
Innovative CDC effort expands HIV testing into pharmacies.
Centers for Disease Control and Prevention, 2012.
Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial.
Choopanya K, et al. Lancet. 2013;381(9883):2083-2090.
Behavioral HIV risk reduction among people who inject drugs: meta-analytic evidence of efficacy.
Copenhaver MM, et al. J Subst Abuse Treat. 2006;31(2):163-171.
Pharmacist-provided rapid HIV testing in two community pharmacies.
Darin KM, et al. J Am Pharm Assoc (2003). 2015;55(1):81-88.
Integrating antiretroviral strategies for human immunodeficiency virus prevention: post- and pre-exposure prophylaxis and early treatment.
Grant RM, Smith DK. Open Forum Infect Dis. 2015;2(4):ofv126.
Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.
Grant RM, et al. N Engl J Med. 2010;363(27):2587-2599.
MSM estimation state profiles.
Grey J, Emory Coalition for Applied Modeling for Prevention (CAMP).
Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial.
McCormack S, et al. Lancet. 2016;387(10013):53-60.
What is PrEP?
PrEP REP project.
Exploratory survey of Florida pharmacists' experience, knowledge, and perception of HIV pre-exposure prophylaxis.
Shaeer KM, et al. J Am Pharm Assoc (2003). 2014;54(6):610-617.
Interactive PresentationPrEP: HIV Pre-Exposure Prophylaxis
Narrated by Richard A. Elion, MD
What Do You Know About PrEP?
Relevant Resources
The PCPs Role in Preventing HIV
What Do You Know About PrEP?
Optimizing Use of Clinical Evidence & Pharmacoeconomic Models in Managed Care
Got it? Treat it!
The Critical Role of the Community Pharmacist
Bringing Local Communities Together to Eliminate Coinfection Through Knowledge and Partnerships.
Volume 1: Rapid ART Initiation: A New Addition to the HIV-Care Tool Box
Key Issues Impacting OB/GYN Practice
Hot Topics in HBV, HCV, and NASH
Volume II: Expanding Evidence for the Role of Rapid ART Initiation in HIV Practice
Why It Matters in OB/GYN Practice Today
A Treater’s Guide to Optimizing Care in the Aging Patient with Comorbidities
How the Pharmacist Can Make a Difference
HIV Can Be Prevented— Are You Doing Your Part?
Rapid Start ART — A New Model for HIV Care
Understanding the Growing Syndemic — Opioids, HCV, and HIV
A PrEP Primer
The PCP’s Role in HCV Elimination
What the Pharmacist Needs to Know about PrEP
The Rapid ART Standard of Care: From Evidence to Healthcare Equity
Maximizing Your Role to Impact Patient Outcomes
Building Bridges to Reach People Who Inject Drugs With the Goal to Eliminate HCV
Benefits, Barriers, & Best Practices in an Advancing Field
Practical Solutions Across the Spectrum of Care
A PEP/PrEP Training Guide for Pharmacists
A Critical Step Toward HCV Elimination
Considering the Patient, the Provider, and the Science
A Multidisciplinary Online Mini-Curriculum
Debates and Discussions about Monoclonal Antibody Therapies
An Update on Monoclonal Antibody Therapies
Establishing Clinical Readiness Through Mentored Learning
Recent Developments in Anti-SARS-CoV-2 Monoclonal Antibodies for Treatment
New Avenues to Pre-Exposure Prophylaxis
